Trial Profile
Phase II Study Trial Of Tarceva In Patients With Recurrent/Progressive Glioblastoma Multiforme
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 22 Aug 2005 New trial record.